Jason Chin, Constructive Bio founder and CSO
September 24, 2024 07:00 AM EDT
Financing
Startups
R&D

Ex­clu­sive: Con­struc­tive Bio rais­es $58M for syn­bio work, and No­bel lau­re­ate joins board

Lei Lei Wu

News Reporter

A UK-based syn­thet­ic bi­ol­o­gy start­up has brought in $58 mil­lion from pri­vate in­vestors to fund its work en­gi­neer­ing cell sys­tems that can man­u­fac­ture new and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

The End­points 100: The biotech in­dus­try braces for Trump 2.0

Dur­ing Covid, RFK Jr. lob­bied against vac­cine EUAs for chil­dren. As HHS sec­re­tary, he could re­scind them

Can­del’s shares soar on Phase 3 prostate can­cer da­ta de­spite un­clear prospects

Gene edit­ing com­pa­nies seek safer, less gru­el­ing con­di­tion­ing meth­ods for blood stem cell ther­a­pies

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times